The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
Once reconstituted, it follows the same strict 28C storage requirements as semaglutide, insulin, and other therapeutic peptides used in clinical settings.
This pharmaceutical-grade diluent is the industry standard for medication reconstitution, peptide preparation, and injectable therapies across hospitals, clinics, compounding pharmacies, and licensed aesthetic practices
With consistent sessions, you may notice enhanced vitality, better focus, and a sense of overall well-being
Glass vials for injection are not designed to be frozen